Saikosaponin b1 Attenuates Liver Fibrosis by Blocking STAT3/Gli1 Interaction and Inducing Gli1 Degradation
Authors:
Open Access
- 3 February 2025
- journal article
- Published by Wiley in Exploration
- Vol. 5 (5)
Abstract
Saikosaponin b1 (Ssb1), a natural oleanane‐type triterpenoid saponin, exhibits antifibrosis activity by inhibiting the activation of hepatic stellate cells (HSCs), but the specific underlying molecular mechanisms are unknown. Here, it is found that Ssb1 could directly bind with the signal transducer and activator of transcription 3 (STAT3) and effectively inhibit the activation of HSCs. Proteomic techniques and molecular simulation revealed that Ssb1 is mainly bound to the S319 residues of STAT3 in the coiled‐coil domain. Further studies indicated that Ssb1 binding with STAT3 inhibited its transcriptional activity, and regulated glioma‐associated oncogene‐1 (Gli1) expression in the Hedgehog signaling pathway. Besides, Ssb1 binding blocked interaction between STAT3 and Gli1, which promoted degradation of Gli1 protein by suppressor of fused homolog (SUFU) and the ubiquitin‐proteasome system. The loss function of Gli1 led to decreased expression of Bcl2 and promoted the apoptosis of activated HSCs. Moreover, STAT3 ablation abolished the Ssb1‐mediated antifibrotic effects. These findings show that STAT3 plays a vital role in Ssb1 treatment of liver fibrosis, and Ssb1 as a STAT3 inhibitor might be a promising therapeutic candidate for the treatment of hepatic fibrosis.Keywords
Funding Information
- National Natural Science Foundation of China (52003246, 81922073, 81973481)
This publication has 52 references indexed in Scilit:
- BCL-2 protein family: attractive targets for cancer therapyApoptosis, 2022
- SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 DimerizationAdvanced Science, 2022
- Saikosaponin B1 and Saikosaponin D inhibit tumor growth in medulloblastoma allograft mice via inhibiting the Hedgehog signaling pathwayJournal of Natural Medicines, 2022
- CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in MiceHepatology, 2019
- Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment ModalitiesDrugs, 2019
- Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cellsMolecular and Cellular Biochemistry, 2018
- Characterization and discrimination of raw and vinegar‐baked Bupleuri radix based on UHPLC‐Q‐TOF‐MS coupled with multivariate statistical analysisBiomedical Chromatography, 2017
- Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in miceHepatology, 2012
- Fibrosis-dependent mechanisms of hepatocarcinogenesisHepatology, 2012
- Now there are many (stages) where before there was oneHepatology, 2010